These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 21729753
1. Endocrine-active chemicals in mammary cancer causation and prevention. Jenkins S, Betancourt AM, Wang J, Lamartiniere CA. J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):191-200. PubMed ID: 21729753 [Abstract] [Full Text] [Related]
2. Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol a and genistein. Betancourt AM, Wang J, Jenkins S, Mobley J, Russo J, Lamartiniere CA. J Nutr; 2012 Jul; 142(7):1382S-8S. PubMed ID: 22649256 [Abstract] [Full Text] [Related]
3. Gestational exposure to the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin induces BRCA-1 promoter hypermethylation and reduces BRCA-1 expression in mammary tissue of rat offspring: preventive effects of resveratrol. Papoutsis AJ, Selmin OI, Borg JL, Romagnolo DF. Mol Carcinog; 2015 Apr; 54(4):261-9. PubMed ID: 24136580 [Abstract] [Full Text] [Related]
4. Prenatal exposure to bisphenol A promotes angiogenesis and alters steroid-mediated responses in the mammary glands of cycling rats. Durando M, Kass L, Perdomo V, Bosquiazzo VL, Luque EH, Muñoz-de-Toro M. J Steroid Biochem Mol Biol; 2011 Oct; 127(1-2):35-43. PubMed ID: 21513798 [Abstract] [Full Text] [Related]
5. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Doherty LF, Bromer JG, Zhou Y, Aldad TS, Taylor HS. Horm Cancer; 2010 Jun; 1(3):146-55. PubMed ID: 21761357 [Abstract] [Full Text] [Related]
6. Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Brown NM, Lamartiniere CA. Environ Health Perspect; 1995 Jun; 103(7-8):708-13. PubMed ID: 7588483 [Abstract] [Full Text] [Related]
7. Cell proliferation and apoptosis in rat mammary glands following combinational exposure to bisphenol A and genistein. Wang J, Jenkins S, Lamartiniere CA. BMC Cancer; 2014 May 29; 14():379. PubMed ID: 24884420 [Abstract] [Full Text] [Related]
8. Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat. Whitsett TG, Lamartiniere CA. Expert Rev Anticancer Ther; 2006 Dec 29; 6(12):1699-706. PubMed ID: 17181483 [Abstract] [Full Text] [Related]
9. Perinatal Exposure to Bisphenol A or Diethylstilbestrol Increases the Susceptibility to Develop Mammary Gland Lesions After Estrogen Replacement Therapy in Middle-Aged Rats. Gomez AL, Delconte MB, Altamirano GA, Vigezzi L, Bosquiazzo VL, Barbisan LF, Ramos JG, Luque EH, Muñoz-de-Toro M, Kass L. Horm Cancer; 2017 Apr 29; 8(2):78-89. PubMed ID: 28078498 [Abstract] [Full Text] [Related]
10. Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer. Eve L, Fervers B, Le Romancer M, Etienne-Selloum N. Int J Mol Sci; 2020 Nov 30; 21(23):. PubMed ID: 33266302 [Abstract] [Full Text] [Related]
11. [Endocrine disrupting chemicals and carcinogenesis--breast, testis and prostate cancer]. Imaida K, Shirai T. Nihon Rinsho; 2000 Dec 30; 58(12):2527-32. PubMed ID: 11187749 [Abstract] [Full Text] [Related]
12. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Fenton SE. Endocrinology; 2006 Jun 30; 147(6 Suppl):S18-24. PubMed ID: 16690811 [Abstract] [Full Text] [Related]
13. Hormone receptor expression in aging mammary tissue and carcinoma from a rodent model after xenoestrogen disruption. Ruiz TFR, Colleta SJ, Zuccari DAPC, Vilamaior PSL, Leonel ECR, Taboga SR. Life Sci; 2021 Nov 15; 285():120010. PubMed ID: 34606849 [Abstract] [Full Text] [Related]
14. Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer. Paulose T, Speroni L, Sonnenschein C, Soto AM. Reprod Toxicol; 2015 Jul 15; 54():58-65. PubMed ID: 25277313 [Abstract] [Full Text] [Related]
15. Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Lamartiniere CA, Zhang JX, Cotroneo MS. Am J Clin Nutr; 1998 Dec 15; 68(6 Suppl):1400S-1405S. PubMed ID: 9848507 [Abstract] [Full Text] [Related]
16. Bisphenol-A: a new diabetogenic factor? Alonso-Magdalena P, Ropero AB, Soriano S, Quesada I, Nadal A. Hormones (Athens); 2010 Dec 15; 9(2):118-26. PubMed ID: 20687395 [Abstract] [Full Text] [Related]
17. In utero estrogenic endocrine disruption alters the stroma to increase extracellular matrix density and mammary gland stiffness. Wormsbaecher C, Hindman AR, Avendano A, Cortes-Medina M, Jones CE, Bushman A, Onua L, Kovalchin CE, Murphy AR, Helber HL, Shapiro A, Voytovitch K, Kuang X, Aguilar-Valenzuela R, Leight JL, Song JW, Burd CJ. Breast Cancer Res; 2020 May 05; 22(1):41. PubMed ID: 32370801 [Abstract] [Full Text] [Related]
18. Bisphenol A (BPA) Exposure In Utero Leads to Immunoregulatory Cytokine Dysregulation in the Mouse Mammary Gland: A Potential Mechanism Programming Breast Cancer Risk. Fischer C, Mamillapalli R, Goetz LG, Jorgenson E, Ilagan Y, Taylor HS. Horm Cancer; 2016 Aug 05; 7(4):241-51. PubMed ID: 26911702 [Abstract] [Full Text] [Related]
19. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. Roy D, Palangat M, Chen CW, Thomas RD, Colerangle J, Atkinson A, Yan ZJ. J Toxicol Environ Health; 1997 Jan 05; 50(1):1-29. PubMed ID: 9015129 [Abstract] [Full Text] [Related]
20. Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis. Brisken C, Hess K, Jeitziner R. Endocrinology; 2015 Oct 05; 156(10):3442-50. PubMed ID: 26241069 [Abstract] [Full Text] [Related] Page: [Next] [New Search]